PRESS RELEASE published on 07/08/2026 at 18:00, 2 months 12 days ago Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Oxurion announces EUR 75,000 capital increase with Atlas Special Opportunities, LLC. Company discloses details following issuance of new shares, increasing total outstanding ordinary shares to 140,734,891 Convertible Bonds Capital Increase Atlas Special Opportunities Oxurion EUR 75,000
PRESS RELEASE published on 07/08/2026 at 18:00, 2 months 12 days ago Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie Atlas Special Opportunities, LLC konvertiert 3 Wandelanleihen von Oxurion, was zu einer Kapitalerhöhung von 75.000 EUR führt. Kapitalstruktur und wichtige Delegationsinformationen von Oxurion NV werden offengelegt Kapitalerhöhung Atlas Special Opportunities Oxurion Wandelanleihen Delegationsinformationen
BRIEF published on 07/06/2026 at 18:35, 2 months 14 days ago Oxurion Launches Exagis eTMF Module to Enhance Clinical Trials Regulatory Compliance Clinical Trials Software Platform Oxurion ETMF Module
BRIEF published on 07/06/2026 at 18:35, 2 months 14 days ago Oxurion lance le module eTMF d'Exagis pour optimiser les essais cliniques Essais Cliniques Oxurion Exagis ETMF Plateforme EClinical
BRIEF published on 07/06/2026 at 18:35, 2 months 14 days ago Oxurion launches Exagis' eTMF module to optimize clinical trials Clinical Trials Oxurion EClinical Platform Exaggerate ETMF
BRIEF published on 07/06/2026 at 18:35, 2 months 14 days ago Oxurion lance le module Exagis eTMF pour améliorer les essais cliniques Conformité Réglementaire Essais Cliniques Plateforme Logicielle Oxurion Module ETMF
PRESS RELEASE published on 07/06/2026 at 18:30, 2 months 14 days ago Oxurion bereikt een nieuwe mijlpaal in de uitbouw van het Exagis-platform met de commerciële lancering van zijn eTMF-module Oxurion NV kündigt die kommerzielle Einführung des Exagis electronic Trial Master File (eTMF)-Moduls an, ein wichtiger Meilenstein in der Umsetzung ihrer Strategie, ein vollständig modulares eClinical-Softwareplattform aufzubauen Oxurion NV Exagis ETMF-Modul Klinische Studien EClinical-Softwareplattform Modulare Plattform
PRESS RELEASE published on 07/06/2026 at 18:30, 2 months 14 days ago Oxurion achieves another milestone in the expansion of the Exagis platform with the commercial launch of its eTMF module Oxurion NV launches Exagis eTMF module, a key milestone in building its eClinical software platform. Designed for clinical research efficiency and regulatory compliance Regulatory Compliance Clinical Research Oxurion NV Exagis ETMF Module EClinical Software Platform
PRESS RELEASE published on 07/06/2026 at 18:30, 2 months 14 days ago Oxurion franchit une nouvelle étape dans le développement de sa plateforme Exagis avec le lancement commercial de son module eTMF Oxurion NV lance le module eTMF d'Exagis, renforçant sa stratégie de plateforme eClinical modulaire et complète Recherche Clinique Oxurion NV Exagis Plateforme EClinical Module ETMF
BRIEF published on 06/26/2026 at 18:05, 2 months 24 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Transparency Notification Shareholding Belgium Atlas Special Opportunities Oxurion
Published on 09/21/2026 at 15:45, 48 minutes ago Datavault AI and Cutting-Edge Sports Management Announce Dream Bowl XV at AT&T Stadium and Launch First-of-Its-Kind Bowl Combine
Published on 09/21/2026 at 14:20, 2 hours 13 minutes ago Doctor's Choice(R) Clinically-Proven Scrubs Launching on Amazon Canada
Published on 09/21/2026 at 14:05, 2 hours 28 minutes ago Winners of this Year's Semmelweis-Richter International Journalism Award Announced
Published on 09/21/2026 at 14:00, 2 hours 33 minutes ago Dateline Files Motion to Resume Operations at Colosseum
Published on 09/21/2026 at 13:45, 2 hours 48 minutes ago Nine Mile Metals DDH WD-26-11 Intersects 2 High Grade VMS Zones Over 27.6M Including 3.08% CU-EQ Over 10.70M, 3.27% CU-EQ Over 9.30M and 4.30% CU-EQ Over 5.0M
Published on 09/21/2026 at 16:19, 14 minutes ago clearvise signs new Power Purchase Agreements on favorable terms
Published on 09/21/2026 at 16:08, 24 minutes ago EQS-Adhoc: EPH Group AG: Purchase agreements signed for the acquisition of an approximately 26,363 m² property in Burgenland
Published on 09/21/2026 at 16:02, 30 minutes ago Press release: Leonteq publishes results of the EGM 2026
Published on 09/21/2026 at 07:00, 9 hours 33 minutes ago Peugeot Invest takes a stake in Mérieux NutriSciences
Published on 09/21/2026 at 07:00, 9 hours 33 minutes ago Peugeot Invest entre au capital de Mérieux NutriSciences
Published on 09/18/2026 at 18:34, 2 days 21 hours ago Disclosure of transactions in own shares from September 14 to September 18, 2026
Published on 09/18/2026 at 18:34, 2 days 21 hours ago Déclaration hebdomadaire d'opérations effectuées du 14 au 18 septembre 2026